About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

42-Year-Old New Zealand Euthanasia Campaigner Dies After Losing Landmark Case

by Bidita Debnath on June 7, 2015 at 12:55 AM
Font : A-A+

42-Year-Old New Zealand Euthanasia Campaigner Dies After Losing Landmark Case

A New Zealand euthanasia campaigner died on Friday just hours after receiving a judgement that rejected her case for assisted suicide, the High Court revealed.

Lecretia Seales, a lawyer suffering from an inoperable brain tumor, launched a landmark legal bid to allow her doctor immunity from prosecution if the medic assisted her death. The 42-year-old's family said she died of natural causes early Friday.

Advertisement

New Zealand's High Court said her death came shortly after she received judge David Collins' ruling that changing the laws on euthanasia was a role for parliament, not the courts.

"Sadly, Ms Seales passed away within hours of receiving the judgment," the High Court said in a statement.

"The judge conveys to Ms Seales? husband, family and friends his deepest condolences."
Advertisement

Seales' legal team had argued that her doctor should be able to help her die if her suffering became intolerable and refusing such assistance would breach her human rights.

Collins ruled that her doctor could be charged with murder for administering a fatal drug, or manslaughter for giving her a dose of drugs to self-administer that led to her death.

"Only parliament can change the law to reflect Ms Seales' wishes the courts cannot trespass on the role of parliament," he said in his judgement.

"The complex legal, philosophical, moral and clinical issues raised by Ms Seales' proceedings can only be addressed by parliament passing legislation to amend the effect of the Crimes Act."

Seales' family said Collins had acknowledged that she was not vulnerable and her wish for assisted death was "a rational and intellectually rigorous response to her circumstances".

"For us, as a family, it is terribly disappointing that the judge was prepared to go as far as he did but not take this last step," they said in a statement.

"The judgment has starkly highlighted that the status quo is not ideal."

They said the case had generated huge public interest and called on parliament, which has stalled previous attempts to debate euthanasia, to comprehensively examine the issue.

"It is clear beyond doubt that people want to debate this issue regardless of their personal position," they said. "The debate needs to happen. The time is now."

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.


Recommended Reading
A Prominent Euthanasia Doctor Banned by Australian Medical Board
Philip Nitschke, a prominent Australian right-to-die doctor vowed on Thursday to continue giving ......
Euthanasia Debate Revived in France With Trial of Mercy Killing Doctor
The debate on euthanasia has been revived in France, where the practice is illegal, with the ......
Chilean Teenager With Cystic Fibrosis Who Asked for Euthanasia on YouTube Passes Away
Valentina Maureira died on May 14 due to complications from the genetic disorder, which attacks the ...
France Allows 'Terminal Sedation' Until Death, not Euthanasia
The French Parliament stopped short of legalizing euthanasia but voted a law allowing medics to ......

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use